Need more? Try out  Advanced Search (20+ criteria)»

logo

Last Update

This profile was last updated on 10/16/2016 and contains contributions from the  Zoominfo Community.

is this you? Claim your profile.

Wrong Peter Kalinka?

Peter Hans Kalinka

Ph.D. Chief Executive Officer

Accelsiors

HQ Phone:  +36 1 299 0091

Direct Phone: +49 **** *******direct phone

GET ZOOMINFO GROW

+ Get 10 Free Contacts a Month

Please agree to the terms and conditions.

I agree to the  Terms of Service and  Privacy Policy. I understand that I will receive a subscription to ZoomInfo Grow at no charge in exchange for downloading and installing the ZoomInfo Contact Contributor utility which, among other features, involves sharing my business contacts as well as headers and signature blocks from emails that I receive.

THANK YOU FOR DOWNLOADING!

computers
  • 1.Download
    ZoomInfo Grow
    v sign
  • 2.Run Installation
    Wizard
  • 3.Check your inbox to
    Sign in to ZoomInfo Grow

I agree to the Terms of Service and Privacy Policy. I understand that I will receive a subscription to ZoomInfo Community Edition at no charge in exchange for downloading and installing the ZoomInfo Contact Contributor utility which, among other features, involves sharing my business contacts as well as headers and signature blocks from emails that I receive.

Accelsiors

Háros u. 103

Budapest, Budapest,1222

Hungary

Company Description

Accelsiors is a scientifically-driven CRO committed to serving the needs of its Sponsors with the highest level of quality. We provide a full array of services and pride ourselves on having ready access to treatment naive patient populations. From consulting w...more

Background Information

Employment History

Head of Clinical Operations

Biotech Companies


Principal

Katan Associates Inc


Head Biochemie Biologics

Sandoz Inc


Instructor for Clinical Development of Pharmaceuticals and Biologics, Advanced Biotechnology Studies

Johns Hopkins University


Key Positions

Serono S.A.


Web References(19 Total References)


Welcome to Katan Associates

www.katanassociates.com [cached]

Peter Hans Kalinka, Ph.D. CEO of the Accelsiors Group International


Welcome to Katan Associates

www.katanassociates.com [cached]

Peter Hans Kalinka, Ph.D. CEO of the Accelsiors Group International
Dr. Kalinka has more that 18 years of experience in the development of therapeutically active proteins in Senior Positions with major Pharmaceutical and Biotech companies. At Serono Headquarters in Geneva, he was deeply involved in the development and first commercialisation of REBIF (Interferon beta-1a). In this function, he was directly responsible for the setting up of Serono ETOMS trial in early Multiple Sclerosis. Working for Novartis, he oversaw the development and filing of the first ?generic? Biopharmaceutical in history, Omnitrope. The product has since been approved by the EMEA and FDA. Dr. Kalinka then spearheaded the development and filing of several other Biopharmaceuticals one of which has also been approved by the EMEA. As Head of Clinical Operations of a venture funded Biotech Company, he directed the simultaneous development of 9 Biopharmaceutical compounds. He planed and implemented the various Phase I through III clinical studies which were carried out concurrently. Dr. Kalinka has held positions such as Senior New Product Manager, Head of Scientific Affairs, Head of Biologics Division and Head of Clinical Operations with companies such as Sandoz, Ares Serono, Novartis and BioPartners. Dr. Kalinka co-founded an international CRO active in Central ? Eastern Europe specialized in difficult indications such as Multiple Sclerosis, Cystic Fibrosis, Hepatitis C and Acromegaly with a significant US and Canadian client base. He is a consultant to the Biotech and Pharmaceutical Industry in all phases of drug development working presently for clients in the USA, Canada Europe, India and Taiwan. Furthermore, Dr. Kalinka teaches Biopharmaceuticals Development at the University of California at Berkeley, CA and Clinical Development of Drugs and Biologics at Johns Hopkins University, MD.


Biosimilars by Biopharm Knowledge Publishing in Biosimilars, Generics Drugs, Regulation & Policy

www.marketresearch.com [cached]

Dr Peter H Kalinka, CEO and Managing Director, Accelsiors Group International
Peter H Kalinka PhD CEO and Managing Director, Accelsiors Group International Instructor for Clinical Development of Pharmaceuticals and Biologics, Advanced Biotechnology Studies, Johns Hopkins


www.pharmaceutical-market-research.com

Dr Peter H Kalinka, CEO and Managing Director, Accelsiors Group International


CRO 2005 Speakers

www.sachsforum.com [cached]

Dr Peter Kalinka, Managing Director, Accelsiors Group


Similar Profiles

city

Browse ZoomInfo's Business
Contact Directory by City

city

Browse ZoomInfo's
Business People Directory

city

Browse ZoomInfo's
Advanced Company Directory